Gain-of-function mutations in ALAS2, the first enzyme of erythroid heme synthesis, cause X-linked dominant protoporphyria (XLPP) in approximatively 4–10% of the patients with erythropoietic protoporphyria [6,7]. The gene discussed is ALAS2; the disease is X-linked erythropoietic protoporphyria.